title: Acute kidney injury: current perspectives.
abstract: Acute kidney injury (AKI) increases morbidity and mortality, particularly for the critically ill. Recent definitions standardizing AKI to reflect graded changes in serum creatinine and urine output (per the Risk, Injury, Failure, Loss, and End-stage renal failure [RIFLE] and Acute Kidney Injury Network [AKIN] criteria) with severity of renal injury and developments in AKI pathobiology are being utilized to identify biomarkers of early kidney injury. These developments may be useful in the early intervention of preventing AKI. Although there has been progress in the management of AKI, therapeutic challenges include appropriate prophylaxis prior to contrast administration, use of diuretics, vasopressors, and the type and dose of renal replacement therapy. Future use of bioartificial dialyzers, plasma therapies, and the possibility of stem cell regeneration of injured kidney tissue are being actively investigated to provide alternative treatment options for AKI. This review aims to provide an overview of current practices, available therapies, and continued research in AKI therapy.
authors.affiliation: VA North Texas Health Care Systems, Dallas VA Medical Center, Dallas, TX 75216, USA. devasmita.dev@va.gov
authors.forename: Devasmita
authors.initials: D
authors.lastname: Choudhury
mesh_terms: D058186:Acute Kidney Injury / Q000175:diagnosis* / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D015415:Biomarkers / Q000097:blood*; D003404:Creatinine / Q000097:blood; D003422:Critical Care / Q000379:methods; D016638:Critical Illness; D055316:Cystatin C / Q000652:urine; D018450:Disease Progression; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D020382:Interleukin-18 / Q000652:urine; D007676:Kidney Failure, Chronic / Q000517:prevention & control* / Q000628:therapy; D007677:Kidney Function Tests; D008297:Male; D011379:Prognosis; D006435:Renal Dialysis / Q000379:methods; D018570:Risk Assessment; D012720:Severity of Illness Index; D016019:Survival Analysis
chemical_list: D015415:Biomarkers; D055316:Cystatin C; D020382:Interleukin-18; D003404:Creatinine